Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

NCT01340326 is registered in ClinicalTrials.gov with Dong-A University as lead sponsor.

NCT NCT01340326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01340326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
Lead sponsor
Dong-A University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2007
Completion date
December 31, 2014
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction